Skip to content

Evaluation of the long-term effects of different acupuncture courses for knee osteoarthritis: a randomized controlled trial

Evaluation of the long-term effects of different acupuncture courses for knee osteoarthritis: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073383
Enrollment
Unknown
Registered
2023-07-10
Start date
2023-07-10
Completion date
Unknown
Last updated
2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis (KOA)

Interventions

4-week acupuncture group :Electro-acupuncture will be administered 3 times a week for a total of 4 weeks
8-week acupuncture group :Electro-acupuncture will be administered 3 times a week for a total of 8 weeks

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 45-75 years (both genders) 2. Diagnosed with KOA according to the ACR criteria 3. Unilateral/bilateral chronic knee pain for over 3 month 4. Radiologic confirmation of KOA within 6 months Kellgren-Lawrence (KL) grade II or III 5. The average score for knee pain during walking on flat ground was 4 or more out of 10 on a numerical rating scale (NRS) in the last week 6. Written informed consent

Exclusion criteria

Exclusion criteria: 1. History of knee surgery or waiting for surgery (knee replacement or arthroscopic knee surgery) 2. Knee pain caused by other diseases (autoimmune diseases, infection, malignant tumours, trauma, fracture, joint loose bodies, severe effusion of joint cavity, lumbosacral vertebrae disease, gout, etc.) 3. Arthroscopy within 1 year and intra-articular injection in the past 6 months 4. Acupuncture treatment during the past 6 months 5. Serious acute or chronic organ diseases or mental disorders 6. Blood coagulation disorders 7. Pregnancy and breastfeeding 8. Cardiac pacemaker and epilepsy 9. Participation in another clinical study within 1 month

Design outcomes

Primary

MeasureTime frame
Response rate ;

Secondary

MeasureTime frame
Response rates at weeks 4, 8 and 16;WOMAC pain subscale;WOMAC function subscale ;WOAMC stiffness subscale;SF-12;Patient global assessment ;The Osteoarthritis Research Society International (OARSI) response rate ;Rescue medicine ;NRS;

Countries

China

Contacts

Public ContactCun-Zhi Liu

Beijing University of Chinese Medicine

lcz_tg@126.com+86 10 5391 2201

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026